Assessing the role of sequencing up to three lines of chemotherapy in metastatic colorectal cancer treatment: A cost effectiveness analysis
Citation:
Toumazis I., Kurt M., Toumazi A., Karacosta L.G., Kwon C., Goldstein D., "Assessing the role of sequencing up to three lines of chemotherapy in metastatic colorectal cancer treatment: A cost effectiveness analysis" The 37th Annual Meeting of the Society of Medical Decision Making, St. Louis, MO, October 18
